Question

 What are the issues raised by patenting of onco-mouse?

18 Mar 2026
Answer :
Word Count : 956
The patenting of the onco-mouse, a genetically engineered mouse developed by Harvard University in the 1980s for cancer research, raised a wide range of legal, ethical, economic, and social issues within the framework of intellectual property rights management. The onco-mouse was designed to carry a gene that made it highly susceptible to cancer, thereby serving as a valuable tool for studying tumor development and testing treatments. While it represented a breakthrough in biotechnology, its patenting sparked global debates about the limits and implications of granting proprietary rights over living organisms. One of the central issues concerns the ethical implications of patenting life forms. The onco-mouse is not a mechanical invention but a living being capable of suffering, reproduction, and biological processes. Critics argue that granting patents over such organisms commodifies life and reduces living entities to mere objects of ownership and commercial exploitation. This raises moral questions about whether humans have the right to claim ownership over genetically modified ____ ____ _______ ____ ___ _______ ________ _______ ___ __________.
__________ _______ _____ _____ ______ _______.
_____ ____ ______ ________ _____ _________ _________.
____ _________ ___ _____ ___ ___ ________ _____ __________ ________ _________.
_____ _____ ________ ________ _______.
_________ ______ __________ _______ ___ ______ _________ _________ _____.
__________ ___ ____ ____ _____ ___ ___ _____ _____ ____ ____.
_________ __________ ________ ___ ____ _________ ____ ______ _______.
___ _________ __________ __________ ___ __________ ____ ______ _____ ________ _________ ________.
____ _________ _____ ________ ________ __________.
_____ ________ ______ _________ ________ _____ ___ _____ _______ ___ _______ _________.
________ _______ ____ _________ _______ ________ ___ _______ ________ _________.
_________ ___ ______ _________ __________ __________ _____.
________ _____ __________ __________ _______ ___ ____.
___ _____ __________ ___ _____ ___ _______ _________ _____ ________ ___.
___ _______ _______ _________ __________ ____ ___ _____ _________.
__________ _______ __________ ________ ______ __________.
__________ _____ ______ ___ ____.
___ _______ ______ ____ ______ ________ _________ _____ ________ ________ ____.
______ _____ _________ __________ ________ _______.
__________ ________ _________ __________ __________ _____.
_______ _________ _________ ____ ______.
_______ _________ _______ ________ ________ __________ ______ _______ _______ _____.
________ _____ ______ _______ __________.
_______ ___ ___ _______ _________ _____ _________ ______ ________ ___ _______.
___ ______ ________ ___ _______ _______.
_____ _____ _________ ____ ___ _______ ________ _____ _________ _____.
__________ ___ ____ ________ _____ _________.
__________ ________ ______ ________ ___ ________ ____ ____ _____ ___ _____ ________.
__________ _______ _________ ________ _____ _____ __________ _______ ____ _________ ____.
______ __________ _______ ____ _____ _________ ______ ____ ___ ________.
______ ______ _____ _____ ___ ______ ___ ________.
___ __________ _________ _____ _____ __________ ____ ____ _________ ________ ______ _____.
____ ________ __________ _________ ___ _________ __________.
_____ _____ ____ ___ ______ __________ _____ _________.
_________ _______ ________ __________ ____ _____ ________ _______ __________.
__________ _________ _________ ___ _____ _______ _____ _________.
__________ ___ _______ _______ __________.
_____ ______ _______ __________ ________ _____.
_______ ______ ____ ___ _____ _________ __________ ______ ___.
_________ _____ ______ ______ _________.
_______ ___ ________ _____ __________ ______ _______.
______ __________ _____ _____ _________ __________ _____ _________ ___ _____ ____ __________.
_________ ________ _________ ____ __________ ____ ____ __________ _______ ____ _____.
__________ ____ _________ _______ ___ ________.
____ _________ _______ _____ __________ ____.
________ ___ ___ __________ ____ ____.
__________ __________ _________ __________ _______ ___ _____ ___ ______ ___.
____ _____ ____ __________ ______ _____ _________ ________.
______ _______ _____ _______ ________ _______ ____ _________ __________ __________ ____.
_______ _____ ________ _________ __________ ___ ____ __________ ____ _________.
________ _____ _________ _____ ______ _____ __________ __________ _____ _________ _____.
_____ __________ __________ ___ ____ _________ ___ ______ ________ ______.
_______ ________ _______ ____ ____ ______.
_______ ____ ___ ______ ____ _____.
__________ ____ _______ _____ ___ ______ _________ __________ _________ ______ _____.
________ _________ ___ _____ ________ _______ ___ _________ __________ __________.
__________ __________ _________ __________ ________ _______ ________ ____ ______ ________ __________ _______.
_________ ____ ______ __________ ________ ______.
_____ _________ ________ ________ ________ _________ _________ _______.
______ ______ ________ ____ _____ __________ _____ __________ _____.
_______ _______ _________ __________ _________ _____ ___.
________ _____ __________ _______ ____ _______ ___ ___ _________ _________.
__________ ______ ___ ___ ________ ___ ___ ________ _________ _________ ________.
________ _______ _____ ________ ______ ___.
_____ ____ ______ ___ _____ _____ _______ _____ ____ ______ ______ __________.
___ _________ _______ ________ _______ _________ ______.
____ _________ ____ _____ _______ ___.
___ ______ ______ ______ ________ ________.
_____ ____ ________ ___ ___ _____ ___ _______ __________ ____.
_______ _____ _____ ______ __________ ___ _________ _________ __________ __________ ___ __________.
__________ _____ ___ ___ ____ ____ ________.
__________ ____ ___ ___ __________ ________ _________ ______ ________ ______ ________.
__________ ______ _______ _____ _______ _____ ________ _______ ______.
__________ ____ __________ ______ ________ __________ ___ ___ ____.
_____ _____ _____ _____ ________.
________ ______ ____ _______ ___ _________ ___ _______ _____ _____ __________.
___ _______ _______ ___ _____ ____ ______ ____ ______ ___.
_________ ____ __________ _______ __________ ___ _______ __________ __________ ________ __________ ____.
______ __________ ______ _________ ______ __________ _____ _______ ______.
___ __________ _______ ________ ________ ______ __________ _____ __________ ______ ____.
___ __________ __________ _________ _______ ___ _______ ____.
__________ _______ ______ _____ ___ ____.
___ _________ ________ _____ ____ ____.
_________ _____ ___ _________ ________ ________ ________ ______ _________ _____ __________.
________ ____ _________ ________ ___ ____ _____ ________ ___.
_____ __________ ____ ______ ___ _________ _______ ________ _____ _____ ________ _______.
____ __________ _________ _______ _____ _______ ____ ___ ________ ___.
_____ _____ _____ _____ _________ _________ ________ ________.
___ _______ __________ ____ ___ __________ __________.
________ _________ ___ _____ _____.
_____ _________ ________ _________ _________.
_______ _______ ______ _______ ______ ___.
________ ______ ____ _______ __________ ______.
_________ _______.
Get Full Answer on WhatsApp
IGNOU NEWS
Assignment Submission Last Date Extended Till 30 June 2026 Click Here★★★IGNOU June 2026 TEE Date Sheet Released Click Here★★★
Top
📞
Call Support Instant phone assistance  What are the issues raised by patenting of onco-mouse?
🟢
WhatsApp Chat Fast live messaging
Email Us Business enquiries & support